Literature DB >> 22647681

miRNA-101: a potential target for tumor therapy.

Ting Gui1, Keng Shen.   

Abstract

microRNAs are genomically encoded small non-coding RNAs that regulate genetic information by controlling stability or translation of mRNAs. Down-regulated expression of microRNA-101 (miRNA-101) has been found in a variety of cancers, and associated with the invasion and progression of malignancies. Recent advances in the understanding of miRNA-101 biogenesis, target recognition and participation in regulatory pathways demonstrate a role for miRNA-101 in tumorigenesis. miRNA-101 gene therapy is of great potentiality to be a new modality for treatment of cancers.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22647681     DOI： 10.1016/j.canep.2012.05.004

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN： 1877-7821            Impact factor:   2.984


  12 in total

1.  Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma.

Authors:  Chun-Yao Li; Yu-Yan Pang; Hong Yang; Jia Li; Hai-Xia Lu; Han-Lin Wang; Wei-Jia Mo; Lan-Shan Huang; Zhen-Bo Feng; Gang Chen
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

Review 2.  Emerging Role of MicroRNAs in mTOR Signaling.

Authors:  Yanjie Zhang; Bo Huang; Hui-Yun Wang; Augustus Chang; X F Steven Zheng
Journal:  Cell Mol Life Sci       Date:  2017-02-25       Impact factor: 9.261

3.  Retracted Article: SNHG3 promotes proliferation and invasion by regulating the miR-101/ZEB1 axis in breast cancer.

Authors:  Liang Chang; Zhuang Hu; Zhenyu Zhou; Hui Zhang
Journal:  RSC Adv       Date:  2018-04-24       Impact factor: 4.036

4.  miR-101 sensitizes A549 NSCLC cell line to CDDP by activating caspase 3-dependent apoptosis.

Authors:  Jiqing Yin; Mingguo Wang; Cuixiang Jin; Qingguo Qi
Journal:  Oncol Lett       Date:  2013-12-03       Impact factor: 2.967

5.  Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.

Authors:  Chun-Yao Li; Dan-Dan Xiong; Chun-Qin Huang; Rong-Quan He; Hai-Wei Liang; Deng-Hua Pan; Han-Lin Wang; Yi-Wen Wang; Hua-Wei Zhu; Gang Chen
Journal:  Med Sci Monit       Date:  2017-04-18

6.  MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.

Authors:  MingHua Li; LinLi Tian; Hui Ren; XiaoXue Chen; Yu Wang; JingChun Ge; ShuLiang Wu; YaNan Sun; Ming Liu; Hui Xiao
Journal:  J Transl Med       Date:  2015-08-19       Impact factor: 5.531

7.  Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma.

Authors:  Min Zheng; Ya-ping Jiang; Wei Chen; Kai-de Li; Xin Liu; Shi-yu Gao; Hao Feng; Sha-sha Wang; Jian Jiang; Xiang-rui Ma; Xiao Cen; Ya-jie Tang; Yu Chen; Yun-feng Lin; Ya-ling Tang; Xin-hua Liang
Journal:  Oncotarget       Date:  2015-03-30

8.  In vitro transfection of anti-tumor miR-101 induces BIM, a pro-apoptotic protein, expression in acute myeloid leukemia (AML).

Authors:  Narges Nikoonahad Lotfabadi; Homa Mohseni Kouchesfahani; Mohammad Hasan Sheikhha; Seyed Mehdi Kalantar
Journal:  EXCLI J       Date:  2017-11-27       Impact factor: 4.068

Review 9.  Non-Coding RNAs as Potential Novel Biomarkers for Early Diagnosis of Hepatic Insulin Resistance.

Authors:  Ariadna Pielok; Krzysztof Marycz
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

10.  Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.

Authors:  Z-S Yao; C Li; D Liang; X-B Jiang; J-J Tang; L-Q Ye; K Yuan; H Ren; Z-D Yang; D-X Jin; S-C Zhang; J-Y Ding; Y-C Tang; J-X Xu; K Chen; W-X Xie; D-Q Guo; J-C Cui
Journal:  Cancer Biomark       Date:  2018       Impact factor: 4.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.